Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.

Authors:
Bao W; Zhang Y; Hang J; Guo Y; Tang W and 8 more

Journal:
Ther Adv Respir Dis

Publication Year: 2022

DOI:
10.1177/17534666221115054

PMCID:
PMC9449520

PMID:
36065527

Journal Information

Full Title: Ther Adv Respir Dis

Abbreviation: Ther Adv Respir Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: BW, ZY, HJ, GY, TW, YC, DJ, JM, LK, YH, ZX, and ZM declare that they have no competing interests. BM was an employee of AstraZeneca at the time of study conduct."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by AstraZeneca. AstraZeneca was involved in the study design, data collection, data analysis, and preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025